Therefore, the HIF-1α inhibitor YC-1 was loaded into transferrin receptor-1-targeting liposomes for delivery to pancreatic tumors to improve hypoxia and anti-tumor effects [88]. The gene discussed is HIF1A; the disease is neoplasm.